MSB 1.99% $1.03 mesoblast limited

Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-327

  1. 5,234 Posts.
    lightbulb Created with Sketch. 430
    Not having your expertise, I sense you are on point.

    Covid has exposed corruption between the FDA and big pharma for what it is. I believe that stem cells and AI are the big movers in the next decade. This is an opportunity for the FDA to get leg up of big pharma and provide them with ultimate leverage. As such i suspect approval in August a slam dunk.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
0.020(1.99%)
Mkt cap ! $1.153B
Open High Low Value Volume
$1.00 $1.04 94.0¢ $10.65M 10.81M

Buyers (Bids)

No. Vol. Price($)
31 99410 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 45321 19
View Market Depth
Last trade - 15.37pm 31/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.